Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Advanced Microfluidics is a Swiss microfluidics company that designs, manufactures, and commercializes industrial and laboratory fluid-handling components and custom systems. Founded in 2014 as a spin-off from EPFL, the company focuses on high-precision microfluidic valves, programmable syringe pumps, rotary valves, and OEM/custom integrated solutions for life science, diagnostics, MedTech, biotech, pharma, and research customers. Its products are intended to enable precise low-volume liquid handling, automation, reduced dead volume, and lower cross-contamination in customer instruments and workflows. The business appears to operate primarily as a tools and component supplier rather than a therapeutics developer, with revenue generated from commercial products and engineering/customization services. Advanced Microfluidics positions itself as a Swiss-quality partner helping customers move microfluidic technologies from development into reliable industrial and laboratory deployment.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Advanced Microfluidics.